Literature DB >> 19372691

Juvenile methylphenidate exposure and factors that influence incentive processing.

Heather C Brenhouse1, Lee Napierata, Lucinda Kussmaul, Melanie Leussis, Susan L Andersen.   

Abstract

Methylphenidate (MPH) is one of the few psychotropic agents approved for use in pediatric populations, underscoring the importance of elucidating any long-term consequences following exposure to this agent. Here, we examined the influence of several variables (i.e. age of assessment, age of exposure, sex, route of administration) on the effect of chronic low-dose MPH (2 mg/kg, twice daily) exposure on place conditioning to cocaine. Juvenile exposure to MPH, but not later exposure, resulted in aversions to cocaine-paired environments when assessed in young adult male rats, but not those entering adolescence. Juvenile MPH enhanced place preferences for cocaine-paired environments in female adolescent rats. The route of administration (i.p. injection or oral ingestion) did not produce enduring differential effects on behavior, and D-MPH was confirmed as the active enantiomer. These observations add to the growing literature on the enduring effects of MPH exposure, and highlight the need for more research in females. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372691      PMCID: PMC5268706          DOI: 10.1159/000207498

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  71 in total

1.  Place conditioning to study drug reward and aversion.

Authors:  William A Carlezon
Journal:  Methods Mol Med       Date:  2003

2.  Methylphenidate-induced plasticity: what should we be looking for?

Authors:  Steven E Hyman
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

Review 3.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

4.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

5.  Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.

Authors:  Patrick N Augustyniak; Said Kourrich; Shohreh M Rezazadeh; Jane Stewart; Andreas Arvanitogiannis
Journal:  Behav Brain Res       Date:  2005-10-24       Impact factor: 3.332

6.  Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

Authors:  N D Volkow; G J Wang; J S Fowler; M Fischman; R Foltin; N N Abumrad; S J Gatley; J Logan; C Wong; A Gifford; Y S Ding; R Hitzemann; N Pappas
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 7.  The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects.

Authors:  Nachum Dafny; Pamela B Yang
Journal:  Brain Res Bull       Date:  2005-10-27       Impact factor: 4.077

8.  Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.

Authors:  S Izenwasser; A E Coy; B Ladenheim; R J Loeloff; J L Cadet; D French
Journal:  Eur J Pharmacol       Date:  1999-06-04       Impact factor: 4.432

9.  Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum.

Authors:  T Chase; N Carrey; E Soo; M Wilkinson
Journal:  Neuroscience       Date:  2006-12-06       Impact factor: 3.590

10.  Pharmacokinetics of methylphenidate in man, rat and monkey.

Authors:  W Wargin; K Patrick; C Kilts; C T Gualtieri; K Ellington; R A Mueller; G Kraemer; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

View more
  13 in total

Review 1.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.

Authors:  Jodi L Lukkes; Nadja Freund; Britta S Thompson; Shirisha Meda; Susan L Andersen
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 4.600

Review 3.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

4.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

5.  Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).

Authors:  Mircea I Chelaru; Pamela B Yang; Nachum Dafny
Journal:  Behav Brain Res       Date:  2011-08-25       Impact factor: 3.332

6.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

Review 7.  Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2011-05-12       Impact factor: 8.989

8.  Drugs for kids: good or bad?

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2012-09       Impact factor: 6.186

9.  Extinction and reinstatement to cocaine-associated cues in male and female juvenile rats and the role of D1 dopamine receptor.

Authors:  Heather C Brenhouse; Britta S Thompson; Kai C Sonntag; Susan L Andersen
Journal:  Neuropharmacology       Date:  2015-03-04       Impact factor: 5.250

Review 10.  Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?

Authors:  Susan L Andersen; Carryl P Navalta
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.